Quantitative Investigation of Desmoplasia as a Prognostic Indicator in Colorectal Cancer

REFERENCES

• Compton CC, Fenoglio-Preiser CM, Pettigrew N, American Joint Committee on Cancer prognostic factors consensus conference. Colorectal working group. Cancer. 2000;88:1739–1757.
   PubMed Web of Science ®Google Scholar
• Kunz-Schughart LA, Knuechel R. Tumor-associated fibroblasts (part I): active stromal participants in tumor development and progression? Histol Histopathol. 2002;17(2):599–621.
   Google Scholar
• Kunz-Schughart LA, Knuechel R. Tumor-associated fibroblasts (part II): functional impact on tumor tissue. Histol Histopathol. 2002;17(2):623–637.
   PubMed Web of Science ®Google Scholar
• Taipale J, Saharinen J, Keski-Ojs J. Extracellular matrix-associated Transforming Growth Factor-b: role in cancer, growth and invasion. Adv Cancer Res. 1998;75:87–134.
   PubMed Web of Science ®Google Scholar
• Chen Y, Abraham DJ, Shi-Wen X, CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin. Mol Biol Cell. 2004;15(12):5635-5646. Epub 2004 Sep 15.
   Google Scholar
• Okano K, Yamamoto J, Kosuge T, Fibrous pseudocapsule of metastatic liver tumors from colorectal carcinoma. Clinicopathologic study of 152 first resection cases. Cancer. 2000;89(2):267–275.
   PubMed Web of Science ®Google Scholar
• Lunevicius R, Nakanishi H, Ito S, Clinicopathological significance of fibrotic capsule formation around liver metastasis from colorectal cancer. J Cancer Res Clin Oncol. 2001;127:193–199.
   PubMed Web of Science ®Google Scholar
• Koliopanos A, Friess H, Di Mola FF, Connective tissue growth factore gene expression alters tumor progression in esophageal cancer. World J Surg. 2002;26:420–427.
   PubMed Web of Science ®Google Scholar
• Hasebe T, Imoto S, Yokose T, Histopathologic factors significantly associated with initial organ-specific metastasis by invasive ductal carcinoma of the breast: a prospective study. Hum Pathol. 2008;39(5):681–693.
   Google Scholar
• Okudera K, Kamata Y, Takanashi S, Small adenocarcinoma of the lung: prognostic significance of central fibrosis chiefly because of its association with angiogenesis and lymphangiogenesis. Pathol Int. 2006;56(9):494–502.
   Google Scholar
• Yang F, Strand DW, Rowley DR. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma. Oncogene. 2008;27(4):450–459.
   Google Scholar
• Caporale A, Cosenza UM, Vestri AR, Has desmoplastic response extent protective action against tumor aggressiveness in gastric carcinoma? J Exp Cancer Res. 2001;20:21–24.
   PubMedGoogle Scholar
• Koperek O, Scheuba C, Cherenko M, Desmoplasia in medullary thyroid carcinoma: a reliable indicator of metastatic potential. Histopathology. 2008;52(5):623–630.
   Google Scholar
• Hartel M, Di Mola FF, Gardini A, Desmoplastic reaction influences pancreatic cancer growth behavior. World J Surg. 2004;28(8):818–825.
   Google Scholar
• Vonlaufen A, Joshi S, Qu C, Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Res. 2008;68(7):2085–2093.
   PubMed Web of Science ®Google Scholar
• Korc M. Pancreatic cancer-associated stroma production. Am J Surg. 2007;194(4 Suppl):S84–S86. Review.
   Google Scholar
• Hewitt RE, Powe DG, Carte I, Desmoplasia and its relevance to colorectal tumor invasion. Int J Cancer. 1993;53:62–69.
   PubMedGoogle Scholar
• Halvorsen TB, Seim E. Association between invasiveness, inflammatory reaction, desmoplasia and survival in colorectal cancer. J Clin Pathol. 1989;42:162–166.
   PubMedGoogle Scholar
• Crispino P, De Toma G, Ciardi A, Role of desmoplasia in recurrence of stage II colorectal cancer within five years after surgery and therapeutic implication. Cancer Invest. 2008;26(4):419–425.
   PubMed Web of Science ®Google Scholar
• Tsujino T, Seshimo I, Yamamoto H, Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clin Cancer Res. 2007;13(7):2082–2090.
   PubMed Web of Science ®Google Scholar
• Bacman D, Merkel S, Croner R, TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study. BMC Cancer. 2007;7:156.
   PubMed Web of Science ®Google Scholar
• Köbel M, Weichert W, Crüwell K, Epithelial hyaluronic acid and CD44v6 are mutually involved in invasion of colorectal adenocarcinomas and linked to patient prognosis. Virchows Arch. 2004;445(5):456–464.
   Google Scholar
• Sis B, Sarioglu S, Sokmen S, Desmoplasia measured by computer assisted image analysis: an independent prognostic marker in colorectal carcinoma. J Clin Pathol. 2005;58(1):32–38.
   Google Scholar
• Caporale A, Vestri AR, Benvenuto E, Is desmoplasia a protective factor for survival in patients with colorectal carcinoma? Clin Gastroenterol Hepatol. 2005;3(4):370–375.
   Google Scholar
• Compton CC, Fielding LP, Burgart LJ, et al. Prognostic factors in colorectal cancer. College of American Pathologists consensus statement 1999. Arch Pathol Lab Med. 2000;124:979–994.
   PubMed Web of Science ®Google Scholar
• Dingemans KP, Zeeman-Boeschoten IM, Keep RF, et al. Transplantation of colon carcinoma into granulation tissue induces an invasive morphotype. Int J Cancer. 1993;54:1010–1016.
   PubMed Web of Science ®Google Scholar
• Sivridis E, Giatromanolaki A, Koukourakis MI. Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress. J Clin Pathol. 2005;58(10):1033–1038.
   PubMed Web of Science ®Google Scholar
• Koukourakis MI, Giatromanolaki A, Harris AL, Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma. Cancer Res. 2006;66(2):632–637.
   PubMed Web of Science ®Google Scholar
• Roxburgh CS, Salmond JM, Horgan PG, Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Ann Surg. 2009;249(5):788–793.
   PubMed Web of Science ®Google Scholar
• Illemann M, Bird N, Majeed A, MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases. Mol Cancer Res. 2006;4(5):293–302.
   Google Scholar